These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 378193)

  • 21. Comparative evaluation of effectivity of bacteriological examination and antibody neutralization reaction during the action of streptomycin on the plague microbe.
    Aparin GP
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):257-62. PubMed ID: 5529576
    [No Abstract]   [Full Text] [Related]  

  • 22. Plague.
    Henderson RJ
    Trop Dis Bull; 1969 Jul; 66(7):653-9. PubMed ID: 4896220
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sensitivity of inbred mice to the causative agent of plague].
    Smirnova LA; Ol'kova NV; Nevradovskiĭ VA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Oct; (10):127-8. PubMed ID: 1210890
    [No Abstract]   [Full Text] [Related]  

  • 24. [Case of the isolation of the causative agent of plague (Yersinia pestis) from the Isabelline wheatear (Oenanthe isabellina Temm.)].
    Shevchenko VL; Grigor'ev IS; Altukhov AA; Mashtakov VI
    Med Parazitol (Mosk); 1980; 49(3):85-6. PubMed ID: 6446677
    [No Abstract]   [Full Text] [Related]  

  • 25. [The biochemical aspects of the pathogenicity of the causative agent of plague].
    Naumov AV; Kuz'michenko IA; Taranenko TM; Korovkin SA; Ermakova GV
    Med Parazitol (Mosk); 1995; (4):17-22. PubMed ID: 8587511
    [No Abstract]   [Full Text] [Related]  

  • 26. STUDIES ON IMMUNIZATION AGAINST PLAGUE. XVII. EXPERIMENTAL STUDIES ON THE EFFECTIVENESS OF ALUMINUM-HYDROXIDE-ADSORBED FORMALIN-KILLED PASTEURELLA PESTIS.
    CHEN TH; LARSON A; MEYER KF
    J Immunol; 1964 Oct; 93():668-76. PubMed ID: 14219083
    [No Abstract]   [Full Text] [Related]  

  • 27. [An experimental study of the ability of the hybrid crosses of Citellophillus tesquorum fleas of 2 subspecies to transmit the causative agent of plague].
    Nikitin AIa; Bazanova LP; Nechaeva LK; Korzun VM; Khabarov AV; Kozets LI
    Med Parazitol (Mosk); 1995; (4):14-7. PubMed ID: 8587510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Enhanced blocking capacity of the plague microbe in the body of the flea].
    Voronova GA
    Parazitologiia; 1989; 23(5):427-9. PubMed ID: 2616196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sepsis-enhancing effect of cobalt-60 irradiation in mice infected with virulent Yersinia pestis on the same day or seven days later.
    Wake A; Long PV; Hien HG; Hirota K
    Contrib Microbiol Immunol; 1995; 13():273-6. PubMed ID: 8833852
    [No Abstract]   [Full Text] [Related]  

  • 30. [Study of protective properties of antigen-containing liposomes of different lipid composition in plague].
    Zakrevskiĭ VI; Plekhanova NG
    Vestn Akad Med Nauk SSSR; 1990; (8):41-4. PubMed ID: 2275277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of Yersinia pestis antigens and strains on the level of lymphocyte blast transformation].
    Ledvanov MIu; Emel'ianova NV; Stukova NIu; Shvedun GP; Taranenko TM; Brandzishevskiĭ IuV
    Med Parazitol (Mosk); 1998; (4):25-7. PubMed ID: 10050549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in the ultrastructure of the plague microbe in the body of guinea pigs under the influence of streptomycin].
    Kenig EE; Zhukov VG; Malinina ZE; Sageeva OF
    Antibiotiki; 1973 Jun; 18(6):546-9. PubMed ID: 4778260
    [No Abstract]   [Full Text] [Related]  

  • 33. The many and varied niches occupied by Yersinia pestis as an arthropod-vectored zoonotic pathogen.
    Oyston PC; Isherwood KE
    Antonie Van Leeuwenhoek; 2005 Apr; 87(3):171-7. PubMed ID: 15803382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Problem of preservation of the causative agent of plague in nature as a methodological task in epidemiology of anthropozoonoses].
    Rotshil'd EV; Ermilov AP; Soldatkin IS
    Med Parazitol (Mosk); 1978; 47(2):101-6. PubMed ID: 651804
    [No Abstract]   [Full Text] [Related]  

  • 35. [Yersinia pestis factors, assuring circulation and maintenance of the plague pathogen in natural foci ecosystems. Report 1].
    Anisimov AP
    Mol Gen Mikrobiol Virusol; 2002; (3):3-23. PubMed ID: 12243063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy of rifampicin in experimental plague infection].
    Makarovskaia LN; Shcherbaniuk AI; Bugaeva OK
    Antibiot Khimioter; 1993 Jul; 38(7):34-6. PubMed ID: 8161275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug resistance in plague.
    Dennis DT; Hughes JM
    N Engl J Med; 1997 Sep; 337(10):702-4. PubMed ID: 9278470
    [No Abstract]   [Full Text] [Related]  

  • 38. [Detection of an inhibitor of the causative agent of plague active against strains of the plague microbe from an homologous focus. The effect of lithium chloride on detecting the inhibitor].
    Gramotina LI
    Antibiot Med Biotekhnol; 1987 Jan; 32(1):36-8. PubMed ID: 3032085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactions of guinea pig subcutaneous connective tissue to direct or long distance exposure to parachlorophenol- or formalin-containing endodontic drugs.
    Thé SD; Maltha JC; Plasschaert AJ
    J Endod; 1981 Jan; 7(1):22-6. PubMed ID: 6938619
    [No Abstract]   [Full Text] [Related]  

  • 40. [Production of L forms of the plague microbe].
    Dunaev GS; Zykin LF; Prozorovskiĭ SV; Kostiukovskiĭ VM; Kurilov VIa
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Oct; (10):85-9. PubMed ID: 747008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.